Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1999-12-21
2002-06-11
Jones, W. Gary (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C435S091210, C435S287200, C536S024300, C536S025320
Reexamination Certificate
active
06403313
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of Invention
The invention relates to methods of sequencing or assaying nucleic acids, and more particularly to methods of assaying triplex and duplex nucleic acid hybridization complexes employing fluorescent intensity measurements.
2. Description of Related Art
Fluorescent dyes have been used to detect and quantitate nucleic acids for decades. In their most basic form, fluorescent intensity-based assays have typically comprised contacting a target with a fluorophore-containing probe, removing any unbound probe from bound probe, and detecting fluorescence in the washed sample. Homogeneous assays improve upon such basic assays, in that the former do not require a washing step or the provision of a non-liquid phase support.
For example, U.S. Pat. No. 5,538,848 to Livak et al. and U.S. Pat. No. 4,220,450 to Maggio disclose homogeneous fluorescence-based assays of nucleotide sequences using oligonucleotide probes in solution. However, these patents require the use of a quenching agent in combination with a reporting agent, so as to distinguish between the signals generated by hybridized probes and unhybridized probes. Livak et al. also requires the use of enzymes in its disclosed method. Quenching agents and enzymes add complexity and expense to the methods.
U.S. Pat. No. 5,332,659 to Kidwell discloses a method for detecting nucleotide sequences in solution using probes comprising at least two fluorophore moieties. The fluorophores must be selected to electronically interact with each other when close enough to vary the wavelength dependence of their spectra. Unhybridized probes are much more flexible than probes hybridized to the target sequence, and consequently the two fluorophore moieties on each probe are more likely to be close to each other when the probe is unhybridized than when the probe is hybridized. Thus, a change in emission wavelength correlated with free probe can be monitored as an indication of the amount of free probe in the sample.
U.S. Pat. No. 5,846,729 to Wu et al. also discloses homogeneous fluorescence-based assays for nucleic acid hybridization.
Some assays have employed intercalating fluorophores to detect nucleic acid hybridization, based on the ability of such fluorophores to bind between strands of nucleic acid in a hybridization complex.
For example, U.S. Pat. No. 5,824,557 to Burke et al. discloses a method and kit for detecting and quantitating nucleic acid molecules. A preferred embodiment relies on the intercalation of a dye into a double-stranded nucleic acid helix or single-stranded nucleic acid. The dye fluoresces after intercalation and the intensity is a direct measurement of the amount of nucleic acid present in the sample. While the method of Burke et al. is purported to be useful for measuring the amount of nucleic acid in a sample, the non-specific binding between intercalator and nucleic acid upon which the method is based renders the method impractical for detecting specific binding, particularly under conditions where non-target nucleic acid duplexes are present.
U.S. Pat. No. 5,814,447 to Ishiguro et al. discloses an assay which is purported to improve upon assays that rely on non-specific interaction between intercalating agents and nucleic acid duplexes, such as Burke et al. and an earlier assay described by Ishiguro et al. in Japanese Patent Public Disclosure No. 237000/1993. The earlier development comprised adding an intercalating fluorochrome having a tendency to exhibit increased intensity of fluorescence when intercalated to a sample solution before a specific region of a target nucleic acid was amplified by PCR, and measuring the intensity of fluorescence from the reaction solution at given time intervals to detect and quantitate the target nucleic acid before amplification. The '447 patent attempted to improve upon the earlier development by providing an assay having improved specificity, characterized in that the probe is a single-stranded oligonucleotide labeled with an intercalating fluorochrome which is to be intercalated into a complementary binding portion between a target nucleic acid and a single-stranded oligonucleotide probe.
In addition to the aforementioned developments which detect fluorescent intensity, some have touted the advantages of fluorescent polarization assays. However, there are significant drawbacks to polarization-based assays. The degree of change in polarization as a function of binding can be unpredictable, and interpretation of data to conform inconsistent data to theoretical expectations can require more effort than is desirable in an analytical method, particularly when the method is to be automated.
Despite the foregoing developments, a need has continued to exist in the art for a simple, highly sensitive, effective and rapid method for analyzing interaction between nucleic acids and/or nucleic acid analogs.
All references cited herein are incorporated herein by reference in their entireties.
SUMMARY OF THE INVENTION
The invention provides a method for assaying binding, said method comprising:
providing a target comprising at least one nucleic acid sequence;
providing a probe comprising a nucleic acid or nucleic acid analog sequence imperfectly complementary to at least a portion of said target;
providing an intercalating agent, wherein either said probe or said intercalating agent comprises a fluorophore;
adding said probe, said target and said intercalating agent to a hybridization medium to provide a test sample;
irradiating said test sample with exciting radiation to cause said fluorophore to emit fluorescent radiation;
detecting an intensity of said fluorescent radiation, wherein said intensity is a direct indication of a binding affinity between said probe and said target; and
determining from said intensity an extent of mismatching between said probe and said target.
REFERENCES:
patent: 4220450 (1980-09-01), Maggio
patent: 4876187 (1989-10-01), Duck et al.
patent: 4963477 (1990-10-01), Tchen
patent: 5011769 (1991-04-01), Duck et al.
patent: 5332659 (1994-07-01), Kidwell
patent: 5403711 (1995-04-01), Walder et al.
patent: 5538848 (1996-07-01), Livak et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5558998 (1996-09-01), Hammond et al.
patent: 5660988 (1997-08-01), Duck et al.
patent: 5705346 (1998-01-01), Okamoto et al.
patent: 5707801 (1998-01-01), Bresser et al.
patent: 5731146 (1998-03-01), Duck et al.
patent: 5800984 (1998-09-01), Vary
patent: 5800992 (1998-09-01), Fodor et al.
patent: 5814447 (1998-09-01), Ishiguro et al.
patent: 5814516 (1998-09-01), Vo-Dinh
patent: 5824477 (1998-10-01), Stanley
patent: 5824557 (1998-10-01), Burke et al.
patent: 5846729 (1998-12-01), Wu et al.
patent: 5861124 (1999-01-01), Hosoi et al.
patent: 5874555 (1999-02-01), Dervan et al.
patent: 5888739 (1999-03-01), Pitner et al.
patent: 5912332 (1999-06-01), Agrawal et al.
patent: 5948897 (1999-09-01), Sen et al.
patent: 6013442 (2000-01-01), Kolesar et al.
patent: 6017709 (2000-02-01), Hardin et al.
patent: 6027880 (2000-02-01), Cronin et al.
patent: 6046004 (2000-04-01), Wu et al.
patent: 6048690 (2000-04-01), Heller et al.
patent: 6060242 (2000-05-01), Nie et al.
patent: 6107078 (2000-08-01), Keese et al.
patent: 6117657 (2000-09-01), Usman et al.
patent: 6251591 (2001-06-01), Wu et al.
patent: 6255050 (2001-07-01), Nie et al.
patent: 6265170 (2001-07-01), Picard et al.
patent: 6312925 (2001-11-01), Meyer, Jr. et al.
patent: 5237000 (1993-09-01), None
Baran et al.,Nucleic Acids Research25:297-303 (1997).
Bohmann et al.,Science, 238:1386-1392 (Dec. 1987).
Chan et al.,J. Mol. Med.75 Issue 4:267-282 (1997).
Dalrymple et al.,Nucleic Acids Research, vol. 13, No. 21, pp. 7865-7879 (1985).
Durland et al.,Biochemistry, 30:9246-9255 (1991).
Floris et al., 260 Eur. J. Biochem. 801-809 (1999).
Hill et al.,Methods in Enzymology, 278:390-416 (1997).
Johansen and Jacobsen,J Biomol Struct Dyn, 16(2):205-22 (1998 Oct) (Abstract).
Kadonaga et al.,Cell, 51:1079-1090 (Dec. 24, 1987).
Kukreti et al. 25Nucleic Acids Research4264-4270 (1997).
Marsh et al.,Nucleic Aci
Daksis Jasmine I.
Erikson Glen H.
Picard Pierre
Caesar Rivise Bernstein Cohen & Pokotilow Ltd.
Forman B J
Ingeneus Corporation
Jones W. Gary
LandOfFree
Fluorescent intensity assay for duplex and triplex nucleic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorescent intensity assay for duplex and triplex nucleic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorescent intensity assay for duplex and triplex nucleic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2892053